Lusutrombopag - Shionogi
Alternative Names: Mulpleo; MULPLETA; Mulpleta; S-888711Latest Information Update: 05 Nov 2023
At a glance
- Originator Shionogi
- Developer Eddingpharm; Shionogi
- Class Small molecules; Thiazoles
- Mechanism of Action Thrombopoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Thrombocytopenia
- Discontinued Idiopathic thrombocytopenic purpura